Le Lézard
Classified in: Health
Subject: RCL

Food Recall Warning (Allergen) - Various Salento Organics brand dark chocolate products recalled due to undeclared milk


Product photos are available: https://recalls-rappels.canada.ca/en/alert-recall/various-salento-organics-brand-dark-chocolate-products-recalled-due-undeclared-milk

OTTAWA, ON, Feb. 25, 2023 /CNW/ -

Summary
Affected products

Brand

Product

Size    

UPC                     

Codes                  

Salento
Organics   

Dark chocolate
pineapple bites

113 g

8 60006 27413 9

Best By 05 2024

L.1022 11

7744061

Salento
Organics

Dark chocolate
pitaya (dragon
fruit) bites

113 g

8 60006 27411 5

Best By 05 2024

L.1022 14

7774061

Salento
Organics

Organic banana
dark chocolate
clusters

113 g

8 60006 27414 6

Best By 02 2024

L.0322 13

5740751

Salento
Organics

Organic peanuts
dark chocolate
dipped                  

113 g

8 60006 27415 3

Best By 02 2024

L.0322 15

5830751

Issue

The affected products are being recalled from the marketplace because they contain milk which is not declared on the label.

The recalled products have been sold in Ontario.

What you should do

Learn more:

Background

This recall was triggered by Canadian Food Inspection Agency test results.

There have been no reported reactions associated with the consumption of these products.

What is being done

The Canadian Food Inspection Agency (CFIA) is conducting a food safety investigation, which may lead to the recall of other products.

The CFIA is verifying that industry is removing recalled products from the marketplace.

SOURCE Canadian Food Inspection Agency (CFIA)


These press releases may also interest you

at 03:20
Calliditas Therapeutics AB (STO: CALTX) ("Calliditas") today announces that its partner Viatris Pharmaceutical Japan G.K. ("Viatris") has initiated a phase III clinical trial in Japan with Nefecon, named VR-205 in the Japanese market, in Japanese...

at 03:00
Global biotechnology leader CSL Behring today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at Hemophilia Treatment Centers in France. This milestone achievement makes HEMGENIX® the...

at 02:30
SOPHiA GENETICS , a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced that Dhiti Omics Technologies, a precision molecular diagnostics service provider in India, is live on the SOPHiA...

at 01:15
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the Phase II/III SKYSCRAPER-06 study, evaluating tiragolumab plus Tecentriq® (atezolizumab) and chemotherapy versus pembrolizumab and chemotherapy as an initial...

at 01:05
BenevolentAI ("BenevolentAI" or the "Company") (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery, announces the appointment of Deutsche Numis as the Company's Financial and Capital Markets Adviser,...

3 jui 2024
YOUR LEGAL RIGHTS MAY BE AFFECTED There is a proposed settlement in a class-action lawsuit filed against Pfizer Inc., Pfizer Ireland Pharmaceuticals, Warner-Lambert Company, and Warner-Lambert Company LLC (collectively, "Pfizer") and Ranbaxy Inc.,...



News published on and distributed by: